Endologix Inc (ELGX):企業の財務・戦略的SWOT分析

◆英語タイトル:Endologix Inc (ELGX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1609
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Endologix Inc (ELGX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Endologix, Inc (Endologix) is a medical device company. It develops, manufactures and markets minimally invasive devices in treatment of aortic diseases. The company incorporates its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company’s AAA products are built on traditional minimally-invasive endovascular repair (EVAR) platform or endovascular sealing (EVAS) platform and Ovation system. The company’s EVAR products include AFX endovascular AAA system, the VELA proximal endograft, the ovation abdominal stent graft system. It has manufacturing facility in Irvine and Santa Rosa, California. The company sells products in the US and six other countries through direct sales force. It also sells products through third-party distributors and agents in Asia Pacific, Latin America, Europe and other targeted international geographies. Endologix is headquartered in Irvine, California, the US.

Endologix Inc Key Recent Developments

Apr 14,2020 Endologix appoints Tim A. Benner as chief commercial officer
Apr 06,2020 Endologix announces preliminary financial results for first quarter 2020
Mar 17,2020 Endologix adds Jane E. Kiernan to its board of directors
Feb 19,2020 Endologix reports fourth quarter and fiscal year 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Endologix Inc – Key Facts
Endologix Inc – Key Employees
Endologix Inc – Key Employee Biographies
Endologix Inc – Major Products and Services
Endologix Inc – History
Endologix Inc – Company Statement
Endologix Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Endologix Inc – Business Description
Geographical Segment: International
Performance
Geographical Segment: The US
Performance
R&D Overview
Endologix Inc – Corporate Strategy
Endologix Inc – SWOT Analysis
SWOT Analysis – Overview
Endologix Inc – Strengths
Endologix Inc – Weaknesses
Endologix Inc – Opportunities
Endologix Inc – Threats
Endologix Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Endologix Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Endologix Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Endologix Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 14, 2020: Endologix appoints Tim A. Benner as chief commercial officer
Apr 06, 2020: Endologix announces preliminary financial results for first quarter 2020
Mar 17, 2020: Endologix adds Jane E. Kiernan to its board of directors
Feb 19, 2020: Endologix reports fourth quarter and fiscal year 2019 financial results
Nov 06, 2019: Endologix reports third quarter 2019 financial results
Aug 08, 2019: Endologix reports second quarter 2019 financial results
May 02, 2019: Endologix reports first quarter 2019 financial results
Feb 25, 2019: Endologix announces fourth quarter and fiscal year 2018 financial results
Jan 10, 2019: Endologix names John D. Zehren as Chief Commercial Officer
Jan 07, 2019: Endologix Announces Fourth Quarter and Full-Year 2018 Preliminary Financial Results and Provides 2019 Financial Guidance
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Endologix Inc, Key Facts
Endologix Inc, Key Employees
Endologix Inc, Key Employee Biographies
Endologix Inc, Major Products and Services
Endologix Inc, History
Endologix Inc, Subsidiaries
Endologix Inc, Key Competitors
Endologix Inc, Ratios based on current share price
Endologix Inc, Annual Ratios
Endologix Inc, Annual Ratios (Cont...1)
Endologix Inc, Interim Ratios
Endologix Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Endologix Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Endologix Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Endologix Inc, Performance Chart (2015 - 2019)
Endologix Inc, Ratio Charts
Endologix Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Endologix Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Endologix Inc (ELGX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Petrofac Ltd (PFC):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrofac Limited (Petrofac) is an oilfield services company that provides integrated services to production and processing industries. It designs and builds oil and gas facilities; operates, maintains and manages facilities on behalf of its customers and trains personnel. It also develops an …
  • Medigus Ltd (MDGS)-医療機器分野:企業M&A・提携分析
    Summary Medigus Ltd (Medigus) is a medical equipment provider that offers endoscopic procedures and devices. The company’s muse system enables endoscopists to treat gastroesophageal reflux disease by performing fundoplication procedures through the mouth. It offers various rigid, semi-flexible and f …
  • AroCell AB (AROC):製薬・医療:M&Aディール及び事業提携情報
    Summary AroCell AB (AroCell), formerly Xi Bao Research AB, is a drug development company that develops and commercializes tests used for the prognosis and monitoring of treatment of cancer. The company develops TK 210 ELISA kits for measuring the enzyme TK1 which is a protein that is elevated in the …
  • University of Bristol-製薬・医療分野:企業M&A・提携分析
    Summary University of Bristol (UOB) is an educational service provider that offers undergraduate and postgraduate courses and research services. The university offers courses in arts, biomedical sciences, engineering, medical and veterinary sciences, dentistry, science, and social sciences and law. …
  • Albert David Ltd (524075):企業の財務・戦略的SWOT分析
    Summary Albert David Ltd (ADL), a subsidiary of Kothari Group is a manufacturer and distributor of pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles. The company’s products include sodium stibogluconate and placentrex. It offers pro …
  • Gulfport Energy Corp (GPOR):石油・ガス:M&Aディール及び事業提携情報
    Summary Gulfport Energy Corp (Gulfport) is an oil and gas company that explores, develops and produces oil and natural gas. The company operates its oil and gas exploration and development assets in Utica Shale, West Cote Blanche Bay Field, Hackberry Field, Athabasca, Peace River oil and Cold Lake o …
  • Westwater Resources, Inc.:企業のM&A・事業提携・投資動向
    Westwater Resources, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westwater Resources, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • SurModics Inc (SRDX):企業の財務・戦略的SWOT分析
    SurModics Inc (SRDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Umpqua Holdings Corporation:企業の戦略・SWOT・財務情報
    Umpqua Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Umpqua Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Xenon Pharmaceuticals Inc (XENE):製薬・医療:M&Aディール及び事業提携情報
    Summary Xenon Pharmaceuticals Inc (Xenon), formerly Xenon Genetics Inc, is a biopharmaceutical company that discovers and develops therapeutics for patients suffering with neurological disorders. The company's pipeline products include XEN1101, XEN901, XEN007 and GDC-0310. It discovers various valid …
  • Commercial Bank International PSC:企業の戦略・SWOT・財務情報
    Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Select Medical Holdings Corporation:企業の戦略・SWOT・財務情報
    Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • G M Breweries Ltd:企業の戦略・SWOT・財務分析
    G M Breweries Ltd - Strategy, SWOT and Corporate Finance Report Summary G M Breweries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Total E&P USA Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Total E&P USA Inc (TEP USA) formerly Elf Exploration Inc, a subsidiary of Total S.A., is an energy service providing company that explores and produces crude oil and natural gas. The company offers offshore oil production and exploration in the Gulf of Mexico to onshore unconventional shale …
  • Yamaha Corporation (7951):企業の財務・戦略的SWOT分析
    Yamaha Corporation (7951) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • General Re Corporation:企業の戦略的SWOT分析
    General Re Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Tokyo Electron Limited:企業の戦略・SWOT・財務分析
    Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report Summary Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Genting Malaysia Berhad:戦略・SWOT・企業財務分析
    Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Avis Budget Group, Inc.:戦略・SWOT・企業財務分析
    Avis Budget Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avis Budget Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kathmandu Holdings Limited:企業の戦略・SWOT・財務分析
    Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆